A novel 4-cM minimally deleted region on chromosome 11p15.1 associated with high grade nonmucinous epithelial ovarian carcinomas

Cancer Research

Volumn 57, Issue 3, 1997, Pages 387-390

  Lu, Karen H ^a   Weitzel, Jeffrey N ^c   Kodali, Srilatha ^a   Welch, William R ^b   Berkowitz, Ross S ^a   Mok, Samuel C ^a,b  

^a Laboratory of Gynecologic Oncology   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 11P; CLINICAL ARTICLE; FEMALE; GENE DELETION; GENE MAPPING; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; INVASIVE CARCINOMA; MUCINOUS CARCINOMA; OVARY CARCINOMA; PRIORITY JOURNAL;

CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 11; FEMALE; HUMANS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS;

EID: 0031049752     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Ehlen, T., and Dubeau, L. Loss of heterozygosity on chromosomal segments 3p, 6q and 11p in human ovarian carcinomas. Oncogene, 5: 219-223, 1990.
2. Weitzel, J. N., Patel, J., Smith, D. M., Goodman, A. K., Safaii, H., and Ball, H. G. Molecular genetic changes associated with ovarian cancer. Gynecol. Oncol., 55: 245-252, 1994.
3. Gallion, H. H., Powell, D., Morrow, J. K., Pieretti, M., Case, E., Turker, M. S., DePriest, P. D., Hunter, J. E., and van Nagell, J. R. Molecular genetic changes in human epithelial ovarian malignancies. Gynecol. Oncol., 47: 137-142, 1992.
4. Cheng, P. C., Gosewehr, J. A., Kim, T. M., Velicescu, F., Wan, M., Zheng, J., Felix, J. C., Gofer, K. F., Luo, P., Biela, B. H., Godorov, G., and Dubeau, L. Potential role of of the inactivated X chromosome in ovarian epithelial tumor development. J. Natl. Cancer Inst., 88: 510-518, 1996.
5. Rodabaugh, K. J., Biggs, R. B., Qureshi, J., Barrett, A., Welch, W., Bell, D., Berkowitz, R., and Mok, S. Detailed deletion mapping of chromosome 9p and p16 gene alterations in human borderline and invasive epithelial ovarian tumors. Oncogene, 11: 1249-1254, 1995.
6. Wertheim, I., Tangir, J., Muto, M., Welch, W., Berkowitz, R. B., Chen, W. Y., and Mok, S. C. Loss of heterozygosity of chromosome 17 in human borderline and invasive epithelial ovarian tumors. Oncogene, 12: 2147-2153, 1996.
7. Pejovic, T., Heim, S., Mandahl, N., Elmfors, B., Floderus, U., Furgyik, S., Helm, G., Willen, H., and Mitelman, F. Consistent occurrence of a 19p+ marker chromosome and loss of 11p material in ovarian seropapillary cystadenocarcinomas. Genes Chromosomes Cancer, 1: 167-171, 1989.
8. Viel, A., Giannini, P., Tumiotto, L., Sopracordevole, P., and Visentin, M. C. Chromosomal localisation of two putative 11p oncosuppressor genes involved in human ovarian tumours. Br. J. Cancer, 66: 1030-1036, 1992.
9. Vandamme, B., Lissens, W., Amfo, K., De Sutter, P., Bourggain, C., Vamos, E., and De Greve, J. Deletion of chromosome 11p13-11p5.5 sequences in invasive human ovarian cancer is a subclonal progression factor. Cancer Res., 52: 6646-6652, 1992.
10. Viel, A., De Pascale, L., Toffoli, G., Tumiotto, L., Miotto, E., and Boiocchi, M. Frequent occurrence of Ha-ras1 allelic deletion in human ovarian adenocarcinomas. Tumori, 77: 16-20, 1991.
11. van't Veer, L. J., Hermans, R., van den Berg-Bakker, L., Cheng, N. C., Fleuren, G. J., Bos, J. L., Cleton, P. J., and Schrier, P. I. Ras oncogene activation in human ovarian carcinoma. Oncogene, 2: 157-165, 1988.
12. Buetow, K., Wever, J., Ludwigsen, S., Scherpbier-Heddema, T., Duyk, G., Sheffield, V., Zhenyuan, W., and Murray, J. Integrated human genome-wide maps constructed using the CEPH reference panel. Nat. Genet., 6: 391-393, 1996.
13. Gyapay, G., Morissette, J., Vignal, A., Dib, C., Fizames, C., Millasseau, P., Marc, S., Bernardi, G., Lathrop, M., and Weissenbach, J. The 1993-93 Genethon human genetic linkage map. Nat. Genet., 7: 246-339, 1994.
14. Litt, M., Kramer, P., Kort, E., Fain, P., Cox, S., Root, D., White, R., Weissenbach, J., Donis-Keller, H., Gatti, R., Wever, J., Nakamura, Y., Julier, C., Hayashi, K., Spurr, N., Dean, M., Mandel, J., Kidd, K., Kruse, T., Retief, A., Bale, A., Meo, T., Vergnaud, G., Warren, S., and Willard, H. The CEPH consortium linkage map of human chromosome 11. Genomics, 27: 101-112, 1995.
15. Lee, J. H., Kavanaugh, J. J., Wildrick, D. M., Wharton, J. T., and Blick, M. Frequent loss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas. Cancer Res., 50: 2724-2728, 1990.
16. Leary, J. A., Doris, C. P., Boltz, E. M., Houghton, C. R. S., Kefford, R. F., and Friedlander, M. L. Investigation of loss of heterozygosity at specific loci on chromosomes 3p, 6q, 11p, 17p and 17q in ovarian cancer. Int. J. Gynecol. Cancer, 3: 293-298, 1993.
17. Gabra, H., Taylor, L., Cohen, B. B., Lessels, A., Eccles, D. M., Leonard, R. C., Smyth, J. F., and Steel, C. M. Chromosome 11 allele imbalance and clinicopathological correlates in ovarian tumours. Br. J. Cancer, 72: 367-375, 1995.
18. Kiechle-Schwarz, M., Bauknecht, T., Wienker, T., Walz, L., and Pfleiderer, A. Loss of constitutional heterozygosity on chromosome 11p in human ovarian cancer positive correlation with grade of differentiation. Cancer (Phila.), 72: 2423-2432, 1993.
19. Zheng, J., Wan, M., Zweizig, S., Velicescu, M., Yu, M. C., and Dubeau, L. Histologically benign or low-grade malignant tumors adjacent to high-grade ovarian carcinomas contain molecular characteristics of high-grade carcinomas. Cancer Res., 53: 4138-4142, 1993.
20. Mok, S. C., Bell, D., Knapp, R. C., Fishbaugh, P. M., Welch, W., Muto, M., Berkowitz, R. B., and Tsao, S. Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy. Cancer Res., 53: 1489-1492, 1993.
21. Ichikawa, Y., Nishida, M., Suzuki, H., Yoshida, S., Tsunoda, H., Kubo, T., Uchida, K., and Miwa, M. Mutation of K-ras protooncogene is associated with histological subtypes in human mucinous ovarian tumors. Cancer Res., 54: 33-35, 1994.
22. Windqvist, R., Hampton, G., Mannermaa, A., Blanco, G., Alavaikko, M., Kiviniemi, H., Taskinen, P., Evans, G., Wright, R., Newsham, I., and Cavenee, W. Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis. Cancer Res., 55: 2660-2664, 1995.
23. Tran, Y. K., and Newsham, I. F. High-density marker analysis of 11p15.5 in non-small cell lung carcinomas reveals allelic deletion of one shared and one distinct region when compared to breast carcinomas. Cancer Res., 56: 2916-2921, 1996.
24. Smith, R., and Rukstalis, D. Frequent loss of heterozygosity at 11p loci in testicular cancer. J. Urol., 153: 1684-1687, 1995.
25. Shaw, M., and Knowles, M. Deletion mapping of chromosome 11 in carcinoma of the bladder. Genes Chromosomes Cancer, 13: 1-8, 1995.